Published in Am J Hypertens on January 01, 2005
Serum phosphorus concentrations and arterial stiffness among individuals with normal kidney function to moderate kidney disease in MESA. Clin J Am Soc Nephrol (2009) 1.67
Structural and functional vascular alterations and incident hypertension in normotensive adults: the Multi-Ethnic Study of Atherosclerosis. Am J Epidemiol (2009) 1.39
Association of pulse pressure, arterial elasticity, and endothelial function with kidney function decline among adults with estimated GFR >60 mL/min/1.73 m(2): the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Kidney Dis (2011) 1.30
Race/ethnic and sex differences in large and small artery elasticity--results of the multi-ethnic study of atherosclerosis (MESA). Ethn Dis (2009) 1.25
Assessment of arterial elasticity among HIV-positive participants with high CD4 cell counts: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial. HIV Med (2015) 1.17
Associations of aortic distensibility and arterial elasticity with long-term visit-to-visit blood pressure variability: the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Hypertens (2013) 1.10
Effect of long-term treatment with antioxidants (vitamin C, vitamin E, coenzyme Q10 and selenium) on arterial compliance, humoral factors and inflammatory markers in patients with multiple cardiovascular risk factors. Nutr Metab (Lond) (2010) 1.04
Reproducibility of arterial elasticity parameters derived from radial artery diastolic pulse contour analysis: the multi-ethnic study of atherosclerosis. Blood Press Monit (2010) 1.02
The differential association of kidney dysfunction with small and large arterial elasticity: the multiethnic study of atherosclerosis. Am J Epidemiol (2009) 0.96
Association between Endothelial Biomarkers and Arterial Elasticity in Young Adults - The CARDIA Study. J Am Soc Hypertens (2010) 0.94
Effect of different types of resistance exercise on arterial compliance and calf blood flow. Eur J Appl Physiol (2011) 0.87
Erectile dysfunction, physical activity and metabolic syndrome: differences in markers of atherosclerosis. BMC Cardiovasc Disord (2011) 0.83
Juice powder concentrate and systemic blood pressure, progression of coronary artery calcium and antioxidant status in hypertensive subjects: a pilot study. Evid Based Complement Alternat Med (2007) 0.82
Acute Cocoa Supplementation Increases Postprandial HDL Cholesterol and Insulin in Obese Adults with Type 2 Diabetes after Consumption of a High-Fat Breakfast. J Nutr (2015) 0.79
Influence of chronic stroke impairments on bone strength index of the tibial distal epiphysis and diaphysis. Osteoporos Int (2014) 0.79
Effects of Resistance Training With and Without Caloric Restriction on Arterial Stiffness in Overweight and Obese Older Adults. Am J Hypertens (2015) 0.79
Effects of an 8-month yoga intervention on arterial compliance and muscle strength in premenopausal women. J Sports Sci Med (2012) 0.78
Subclinical impairment of arterial mechanics in systemic lupus erythematosus identified by arterial waveform analysis. Rheumatol Int (2007) 0.77
Differences in galectin-3, a biomarker of fibrosis, between participants with peripheral artery disease and participants with normal ankle-brachial index. Vasc Med (2016) 0.76
Invited Commentary: Hypertension and Arterial Stiffness-Origins Remain a Dilemma. Am J Epidemiol (2016) 0.75
Associations of kidney injury markers with subclinical cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis. Clin Nephrol (2015) 0.75
Early Antiretroviral Therapy at High CD4 Counts Does Not Improve Arterial Elasticity: A Substudy of the Strategic Timing of AntiRetroviral Treatment (START) Trial. Open Forum Infect Dis (2016) 0.75
Relative impact of neuromuscular and cardiovascular factors on bone strength index of the hemiparetic distal radius epiphysis among individuals with chronic stroke. Osteoporos Int (2012) 0.75
Long-term use of ticagrelor in patients with prior myocardial infarction. N Engl J Med (2015) 8.69
Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J (2005) 6.86
Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection. J Infect Dis (2010) 5.35
Prasugrel versus clopidogrel for acute coronary syndromes without revascularization. N Engl J Med (2012) 4.49
Renal damage in primary aldosteronism: results of the PAPY Study. Hypertension (2006) 4.20
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol (2006) 3.74
Clinical applications of arterial stiffness; definitions and reference values. Am J Hypertens (2002) 3.43
Interruption of antiretroviral therapy and risk of cardiovascular disease in persons with HIV-1 infection: exploratory analyses from the SMART trial. Antivir Ther (2008) 2.93
Effects of melatonin and Pycnogenol on small artery structure and function in spontaneously hypertensive rats. Hypertension (2010) 2.81
Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis. BMJ (2014) 2.62
Clinical applications of arterial stiffness, Task Force III: recommendations for user procedures. Am J Hypertens (2002) 2.35
Left ventricular concentric geometry during treatment adversely affects cardiovascular prognosis in hypertensive patients. Hypertension (2004) 2.31
Relation of N-terminal pro B-type natriuretic peptide to progression of aortic valve disease. Eur Heart J (2005) 2.25
Release kinetics of circulating muscle-enriched microRNAs in patients undergoing transcoronary ablation of septal hypertrophy. J Am Coll Cardiol (2013) 2.25
Remifentanil: a novel systemic analgesic for labor pain. Anesth Analg (2005) 2.23
Changes in inflammatory and coagulation biomarkers: a randomized comparison of immediate versus deferred antiretroviral therapy in patients with HIV infection. J Acquir Immune Defic Syndr (2011) 2.21
Prognostic role of flow-mediated dilatation of the brachial artery in hypertensive patients. J Hypertens (2008) 2.18
Effects of the selective aldosterone blocker eplerenone versus the calcium antagonist amlodipine in systolic hypertension. Hypertension (2003) 2.06
Incomplete inhibition of thromboxane biosynthesis by acetylsalicylic acid: determinants and effect on cardiovascular risk. Circulation (2008) 2.05
Effect of antihypertensive treatment on microvascular structure, central blood pressure and oxidative stress in patients with mild essential hypertension. J Hypertens (2014) 2.03
Incretin, insulinotropic and glucose-lowering effects of whey protein pre-load in type 2 diabetes: a randomised clinical trial. Diabetologia (2014) 2.02
How to use high-sensitivity cardiac troponins in acute cardiac care. Eur Heart J (2012) 2.00
Recommendations for the use of cardiac troponin measurement in acute cardiac care. Eur Heart J (2010) 1.88
Human hibernating myocardium is jeopardized by apoptotic and autophagic cell death. J Am Coll Cardiol (2004) 1.88
Development of diagnostic criteria for serious non-AIDS events in HIV clinical trials. HIV Clin Trials (2010) 1.75
Vascular remodeling and duration of hypertension predict outcome of adrenalectomy in primary aldosteronism patients. Hypertension (2008) 1.69
2014 ESC/EACTS guidelines on myocardial revascularization. Rev Esp Cardiol (Engl Ed) (2015) 1.69
Inappropriate left ventricular mass in patients with primary aldosteronism. Hypertension (2008) 1.67
Determination of the underlying cause of death in three multicenter international HIV clinical trials. HIV Clin Trials (2008) 1.65
Identification of the epidural space: loss of resistance with air, lidocaine, or the combination of air and lidocaine. Anesth Analg (2004) 1.59
Structural alterations of subcutaneous small-resistance arteries may predict major cardiovascular events in patients with hypertension. Am J Hypertens (2007) 1.59
Screening for early detection of cardiovascular disease in asymptomatic individuals. Am Heart J (2003) 1.58
N-terminal B-type natriuretic peptide predicts extent of coronary artery disease and ischemia in patients with stable angina pectoris. Am Heart J (2004) 1.57
Usefulness of B-type natriuretic peptide assay in the assessment of symptomatic state in hypertrophic cardiomyopathy. Circulation (2004) 1.56
Treatment with insulin sensitizer metformin improves arterial properties, metabolic parameters, and liver function in patients with nonalcoholic fatty liver disease: a randomized, placebo-controlled trial. Metabolism (2011) 1.54
Predistention of the epidural space before catheter insertion reduces the incidence of intravascular epidural catheter insertion. Anesth Analg (2007) 1.50
Does a colonoscopy after acute diverticulitis affect its management?: a single center experience. J Clin Gastroenterol (2012) 1.50
Effect of gender differences on early and mid-term clinical outcome after percutaneous or surgical coronary revascularisation in patients with multivessel coronary artery disease: insights from ARTS I and ARTS II. EuroIntervention (2009) 1.48
High-density lipoprotein particles and markers of inflammation and thrombotic activity in patients with untreated HIV infection. J Infect Dis (2010) 1.46
Structural alterations in subcutaneous small resistance arteries predict changes in the renal function of hypertensive patients. J Hypertens (2010) 1.46
Diagnosing brain death using the transcranial Doppler with a transorbital approach. Arch Neurol (2002) 1.46
Within-patient reproducibility of the aldosterone: renin ratio in primary aldosteronism. Hypertension (2009) 1.45
Five-year long-term clinical follow-up of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo coronary artery lesions: the SPIRIT FIRST trial. Catheter Cardiovasc Interv (2010) 1.43
The German CPU Registry: comparison of troponin positive to troponin negative patients. Int J Cardiol (2013) 1.43
Cognitive decline and ischemic microlesions after coronary catheterization. A comparison to coronary artery bypass grafting. Am Heart J (2011) 1.43
A randomized comparison of a durable polymer Everolimus-eluting stent with a bare metal coronary stent: The SPIRIT first trial. EuroIntervention (2005) 1.42
Recommendations for the use of natriuretic peptides in acute cardiac care: a position statement from the Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care. Eur Heart J (2011) 1.42
Adrenergic mechanisms and remodeling of subcutaneous small resistance arteries in humans. J Hypertens (2003) 1.42
The effect of intermittent versus continuous bladder catheterization on labor duration and postpartum urinary retention and infection: a randomized trial. J Clin Anesth (2008) 1.41
The effect of pre-hospital glycoprotein IIb-IIIa inhibitors on angiographic outcome in STEMI patients who are candidates for primary PCI. Catheter Cardiovasc Interv (2011) 1.41
Predictors of failed colonoscopy in nonagenarians: a single-center experience. J Clin Gastroenterol (2007) 1.41
Pulmonary function is associated with distal aortic calcium, not proximal aortic distensibility. MESA lung study. COPD (2011) 1.41
Structural changes in small resistance arteries and left ventricular geometry in patients with primary and secondary hypertension. J Hypertens (2002) 1.41
Untreated HIV infection and large and small artery elasticity. J Acquir Immune Defic Syndr (2009) 1.41
Diagnostic and prognostic value of N-terminal pro B-type natriuretic peptide (NT-proBNP) in patients with chronic aortic regurgitation. Int J Cardiol (2007) 1.40
Diagnostic clues for identification of nonorganic vs organic causes of food refusal and poor feeding. J Pediatr Gastroenterol Nutr (2009) 1.39
Blockade of the renin-angiotensin system in small arteries and anticontractile function of perivascular adipose tissue. J Hypertens (2015) 1.39
Tako-Tsubo cardiomyopathy: NT-proBNP as a reliable parameter of a favourable prognosis? Int J Cardiol (2007) 1.39
Structural and functional vascular alterations and incident hypertension in normotensive adults: the Multi-Ethnic Study of Atherosclerosis. Am J Epidemiol (2009) 1.39
Body mass index predicts plasma aldosterone concentrations in overweight-obese primary hypertensive patients. J Clin Endocrinol Metab (2008) 1.38
Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine. Heart (2006) 1.38
Pretreatment with prasugrel in non-ST-segment elevation acute coronary syndromes. N Engl J Med (2013) 1.32
Comparison of clinical characteristics of patients with gastroesophageal reflux disease who failed proton pump inhibitor therapy versus those who fully responded. J Neurogastroenterol Motil (2011) 1.32
Neuropsychiatric syndromes in systemic lupus erythematosus: a meta-analysis. Semin Arthritis Rheum (2010) 1.31
Application of Maastricht 2-2000 guidelines for the management of Helicobacter pylori among specialists and primary care physicians in israel: are we missing the malignant potential of Helicobacter pylori? J Clin Gastroenterol (2004) 1.27
Prolactin and autoimmunity. Autoimmun Rev (2011) 1.24
Severe hypophosphatemia in sepsis as a mortality predictor. Ann Clin Lab Sci (2006) 1.23
Short-term outcome of patients with ST-segment elevation myocardial infarction (STEMI) treated with an everolimus-eluting bioresorbable vascular scaffold. Clin Res Cardiol (2013) 1.22
5-year clinical outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the sirolimus-eluting stent in the treatment of patients with multivessel de novo coronary artery lesions. J Am Coll Cardiol (2010) 1.21
Diet quality indexes and mortality in postmenopausal women: the Iowa Women's Health Study. Am J Clin Nutr (2013) 1.19
Parathyroid hormone and arterial dysfunction in the multi-ethnic study of atherosclerosis. Clin Endocrinol (Oxf) (2013) 1.16
Efficacy of ozone-oxygen therapy for the treatment of diabetic foot ulcers. Diabetes Technol Ther (2011) 1.16
Small artery structure and hypertension: adaptive changes and target organ damage. J Hypertens (2005) 1.13
Prompt correction of endotracheal tube positioning after intubation prevents further inappropriate positions. J Clin Anesth (2011) 1.13
Cardiovascular influences of alpha1b-adrenergic receptor defect in mice. Circulation (2002) 1.13
Decreased pulmonary perfusion in pulmonary vein stenosis after radiofrequency ablation: assessment with dynamic magnetic resonance perfusion imaging. Chest (2004) 1.13
Comparison of the captopril and the saline infusion test for excluding aldosterone-producing adenoma. Hypertension (2007) 1.13
Novel rat model reveals important roles of β-adrenoreceptors in stress-induced cardiomyopathy. Int J Cardiol (2013) 1.11
2014 ESC/EACTS guidelines on myocardial revascularization. EuroIntervention (2015) 1.08
Perovskites as substitutes of noble metals for heterogeneous catalysis: dream or reality. Chem Rev (2014) 1.08
Extrapancreatic autoimmune manifestations in type 1 diabetes patients and their first-degree relatives: a multicenter study. Diabetes Care (2003) 1.06
Prospective randomized comparison of laparoscopic versus open adrenalectomy for sporadic pheochromocytoma. Surg Endosc (2008) 1.06
Olive leaf extract as a hypoglycemic agent in both human diabetic subjects and in rats. J Med Food (2012) 1.06
Beneficial neurohormonal profile of spironolactone in severe congestive heart failure: results from the RALES neurohormonal substudy. J Am Coll Cardiol (2002) 1.06
Pediatric Crohn's disease and growth retardation: the role of genotype, phenotype, and disease severity. Pediatrics (2004) 1.05
HIV replication alters the composition of extrinsic pathway coagulation factors and increases thrombin generation. J Am Heart Assoc (2013) 1.04
Implementation of reperfusion therapy in acute myocardial infarction. A policy statement from the European Society of Cardiology. Eur Heart J (2005) 1.03
Improved diagnostic and prognostic performance of a new high-sensitive troponin T assay in patients with acute coronary syndrome. Am Heart J (2011) 1.03
Body mass index is inversely related to mortality in elderly subjects. J Gen Intern Med (2007) 1.02
Tirofiban as adjunctive therapy for acute coronary syndromes and percutaneous coronary intervention: a meta-analysis of randomized trials. Eur Heart J (2009) 1.02
Challenges of coronary angiography and intervention in patients previously treated by TAVI. Clin Res Cardiol (2015) 1.01